Issue 31, 2018

In vivo drug tracking with 19F MRI at therapeutic dose

Abstract

Tracking drugs with 19F MRI would be beneficial for developing theranostics and optimizing drug therapy. To this end, a fluorinated dendritic amphiphile with high 19F MRI sensitivity and biocompatibility has been developed for 19F MRI tracking of doxorubicin (DOX)-loaded liposomes in mice, which may provide an effective platform to in vivo trace various drugs with 19F MRI.

Graphical abstract: In vivo drug tracking with 19F MRI at therapeutic dose

Supplementary files

Article information

Article type
Communication
Submitted
27 Dec 2017
Accepted
21 Mar 2018
First published
21 Mar 2018

Chem. Commun., 2018,54, 3875-3878

In vivo drug tracking with 19F MRI at therapeutic dose

S. Bo, Y. Yuan, Y. Chen, Z. Yang, S. Chen, X. Zhou and Z. Jiang, Chem. Commun., 2018, 54, 3875 DOI: 10.1039/C7CC09898G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements